SCD and neoplasm: Reduced cholesterol is likely responsible for decreased membrane fluidity corroborated by increased contents of monounsatured fatty acids produced by elevated SCD1. Recently, it has been reported that in breast cancer, cholesterol metabolites can either promote (e.g. 27-hydroxycholesterol) or inhibit tumor formation (e.g. dendrogenin A) [24].